However, in a sensitivity analysis of the REWIND study with dulaglutide, the relative risk reduction for a 40% or 50% decrease in eGFR was 30% and 44%, both significant, in the dulaglutide group compared to placebo, respectively.92 This lower risk of developing macroalbuminuria was also confirmed in an exploratory analysis of the ELIXA (lixisenatide) study.93 In the EXSCEL study (exenatide LAR), renal episodes were analyzed as additional microvascular episodes, and no differences were observed in the risk of episodes related to decreased eGFR, but differences were observed in the composite episode, which included decreased eGFR and macroalbuminuria, although only after adjustment94 (Table 2)
Many women are prescribed Mounjaro during perimenopause or menopause as part of obesity or weight-management treatment
Adding keto to this pair can produce excellent blood sugar control and weight loss, but it also increases the risk of lactic acidosis (rare but serious with metformin) and hypoglycemia (low blood sugar) because three separate mechanisms are all working to lower blood glucose simultaneously
Their mechanisms - slowing gastric emptying, increasing satiety, and reducing appetite - have made them highly effective options for obesity treatment
Talenezhad, N., Mohammadi, M., Ramezani-Jolfaie, N., et al
Can I take it if I dont have diabetes
